Sun, Thomas Yang

U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors

Papadopoulos, K. P., Borazanci, E., Shaw, A. T., Katayama, R., Shimizu, Y., Zhu, V. W., Sun, T. Y., Wakelee, H. A., Madison, R., Schrock, A. B., et al. (2020) · Clinical Cancer Research

Lung Cancer Treatments and MutationsCancer Mechanisms and Therapy

Cited by 113

DNase Inhibits Gardnerella vaginalis Biofilms In Vitro and In Vivo

Hymes, S. R., Randis, T. M., Sun, T. Y., & Ratner, A. J. (2013) · The Journal of Infectious Diseases

Reproductive tract infections researchBacterial biofilms and quorum sensing

Cited by 96